Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149 is registered in ClinicalTrials.gov with International Extranodal Lymphoma Study Group (IELSG) as lead sponsor.

NCT NCT05700149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
Lead sponsor
International Extranodal Lymphoma Study Group (IELSG)
Phase
Observational
Overall status
Recruiting
Start date
April 11, 2024
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

nodal marginal zone lymphoma